Final rule 2025-01840
Nonprescription Drug Product With an Additional Condition for Nonprescription Use
In accordance with the memorandum of January 20, 2025, from the President, entitled "Regulatory Freeze Pending Review," the effective date of the final rule, entitled "Nonprescription Drug Product With an Additional Condition for Nonprescription Use," (ACNU) is delayed until March 21, 2025.
Source-supplied record
Document details
- Document number
- 2025-01840
- Published
- Jan 27, 2025
- Effective
- Mar 21, 2025
- Comments close
- Not supplied
- Federal Register citation
- 90 FR 8173
Docket identifiers
- Docket No. FDA-2021-N-0862
CFR references
- Title 21, part 201
- Title 21, part 314